Description  Claims  Drawing  Cited references 

US61907013B   [0001] 
WO2012078053A   [0013] 

Proper evaluation of asymptomatic microscopic hematuria in the era of evidence-based medicine-progress is being made   [0004]  [0226] 
Assessment of Microscopic hematuria in adults   [0004]  [0226] 
Asymptomatic microscopic hematuria in adults: summary of AUA best practice policy recommendations   [0004]  [0226] 
Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria   [0005]  [0226] 
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder   [0013] 
A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria   [0013]  [0226] 
PCR Technique: Quantitative PCR   [0048] 
A-Z of Quantitative PCR   [0048] 
Current Protocols in Molecular Biology   [0048] 
Molecular Cloning: A Laboratory Manual   [0048] 
Molecular Cloning: A Laboratory Manual   [0050] 
Oligonucleotide Synthesis   [0050] 
Animal Cell Culture   [0050] 
Methods in Enzymology   [0050] 
Handbook of Experimental Immunology   [0050] 
Gene Transfer Vectors for Mammalian Cells   [0050] 
Current Protocols in Molecular Biology   [0050] 
PCR: The Polymerase Chain Reaction   [0050] 
Molecular Cloning: A Laboratory Manual 3   [0088] 
Genome Research   [0096] 
Genome Res.   [0097] 
Primer3 on the VIMNV for general users and for biologist programmers   [0098] 
General Concepts for PCR Primer Design   [0099] 
Optimization of PCRs   [0099] 
Primerselect: Primer and probe design   [0099] 
Proc. Natl. Acad. Sci. USA   [0103] 
Current Protocols of Molecular Biology   [0104] 
Lab Invest   [0104] 
BioTechniques   [0104] 
J. Molec. Diagnostics   [0105] 
Am. J. Pathol.   [0105] 
Molecular Cloning: A Laboratory Manual 3   [0108] 
Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens   [0108] 
Application of magnetic beads in bioassays   [0108] 
A Bead-Based Method for Multiplexed Identification and Quantitation of DNA Sequences Using Flow Cytometry   [0108] 
The ELISA guidebook   [0111] 
Using antibodies: a laboratory manual   [0111]  [0114] 
Phage display vectors for the in vitro generation of human antibody fragments   [0111] 
Modern Applied Statistics with S   [0177] 
R Development Core Team   [0177] 
R: A language and environment for statistical computing   [0190] 
Approximate is better than ''ex- act'' for interval estimation of binomial proportions   [0226] 
SEER Cancer Statistics Review   [0226] 
Interval estimation for a binomial proportion   [0226] 
Cancer Research   [0226] 
A limited memory algorithm for bound constrained optimization   [0226] 
Introductory Statistics with R   [0226] 
Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach   [0226] 
The five-parameter logistic: A characterization and comparison with the four-parameter logistic   [0226] 
Laryngoscope   [0226] 
Application of ridge analysis to regression problems   [0226] 
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder   [0226] 
AJ. American Cancer Society   [0226] 
JAMA   [0226] 
Cancer Epidemiol. Biomarkers Pre   [0226] 
Clin. Chim. Acta.   [0226] 
Urology   [0226] 
The BUGS project: Evolution, critique and future directions (with discussion)   [0226] 
Cancer   [0226] 
Prostate Cancer Prostatic Dis.   [0226] 
J. Clin. Endocrinol. Metab.   [0226] 
Clin. Chem.   [0226] 
The Levenberg-Marquardt algorithm: implementation and theory   [0226] 
A simplex algorithm for function minimization   [0226] 
Cancer Immunol. Immunother.   [0226] 
R: A language and environment for statistical computing   [0226] 
A flexible growth function for empirical use   [0226] 
Cancer Rese arch   [0226] 
ROCR: Visualizing the performance of scoring classifiers   [0226] 
Highly accurate sigmoidal fitting of realtime RCR data by introducing a parameter for asymmetry   [0226] 
Structure, genomic organization, and expression of the human interleukin-8 receptor B gene   [0226] 
Stata Statistical Software: Release 11   [0226] 
Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria   [0226] 
I Clin Endocrinol Metab   [0226]  [0226] 
Modern Applied Statistics with S   [0226] 
Dim Lab. Med.   [0226] 
Cancer Letters   [0226] 
Assessment and management of non-visible haematuria in primary care   [0273] 
Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline   [0273] 
Evaluation of hematuria in adults   [0273] 
A prospective analysis of 1,930 patients with hematuria to evaluate clinical practice   [0273] 
Re-design of a haematuria clinic: Assessment of 2346 haematuria patients   [0273] 
Non-visible versus visible haematuria and bladder cancer risk: A study of electronic records in primary care   [0273] 
What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up   [0273] 
Evaluation and management of hematuria   [0273] 
The risk of urinary tract infection after flexible cystoscopy in bladder tumor patients who did not receive prophylactic antibiotics   [0273] 
The community-based morbidity of flexible cystoscopy   [0273] 
Adverse effects of cystoscopy and its impact on patients' quality of life and sexual performance   [0273] 
How to evaluate 'dipstick hematuria': What to do before you refer   [0273] 
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation   [0273] 
Urine cytology in the evaluation of urological malignancy revisited: is it still necessary?   [0273] 
Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients   [0273] 
The economics of bladder cancer: Costs and considerations of caring for this disease   [0273] 
Detection of bladder cancer using a point-of-care proteomic assay   [0273] 
Variation in the intensity of hematuria evaluation: a target for primary care quality improvement   [0273] 
Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis   [0273] 
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer   [0273] 
Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria   [0273] 
Stratifying patients with haematuria into high or low risk groups for bladder cancer: a novel clinical scoring system   [0273] 
Microscopic haematuria: urological investigation using a standard protocol   [0273] 
Microscopic hematuria as a screening marker for urinary tract malignancies   [0273] 
Is routine urine cytology useful in the haematuria clinic?   [0273] 
Early results of bladder-cancer screening in a high-risk population of heavy smokers   [0273] 
The health economics of bladder cancer: An updated review of the published literature   [0273] 
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder   [0273] 
Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?   [0273] 
Combination of molecular alterations and smoking intensity predicts bladder cancer outcome   [0273] 
Prospective external validation of model for bladder cancer detection   [0273] 
The impact of biomarkers in multi- variate algorithms for bladder cancer diagnosis in patients with hematuria   [0273] 
A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria   [0273] 
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee   [0273] 
An introduction to the bootstrap   [0273] 
Bootstrap confidence intervals   [0273] 
Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: A decision analysis   [0273] 
Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: A meta-analysis   [0273] 
Aberdeen Technology Assessment Review (TAR) Group: Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis   [0273] 
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic   [0273] 
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection   [0273] 
A breast cancer prediction model incorporating familial and personal risk factors   [0273] 
on behalf the Austrian Breast and Colorectal Cancer Study Group (ABCSG): The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients   [0273] 
Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK   [0273] 
Austrian Breast and Colorectal Cancer Study Group: The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer   [0273] 
Bladder Cancer Risk: Use of the PLCO and NLST to Identify as Suitable Screening Cohort   [0273]